Science · 1994 · 1.4K citations · 20 references
MedicineCancer BiologyMolecular GeneticsGene ExpressionMolecular OncologyTumor ProgressionAngiogenesisCancer-associated FibroblastsTumor Suppressor GenesAngiogenesis ImpairmentLi-fraumeni SyndromeP53 InactivationP53 MutationTp53 MutationsTumor Suppressor Gene LossTumor Suppressor Gene MutationsTumor Suppressor P53
As normal cells progress toward malignancy, they must switch to an angiogenic phenotype to attract the nourishing vasculature that they depend on for their growth. In cultured fibroblasts from Li-Fraumeni patients, this switch was found to coincide with loss of the wild-type allele of the p53 tumor suppressor gene and to be the result of reduced expression of thrombospondin-1 (TSP-1), a potent inhibitor of angiogenesis. Transfection assays revealed that p53 can stimulate the endogenous TSP-1 gene and positively regulate TSP-1 promoter sequences. These data indicate that, in fibroblasts, wild-type p53 inhibits angiogenesis through regulation of TSP-1 synthesis.
20
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
David Malkin, Frederick P. Li, Louise C. Strong et al. · Science · 1990 · 3.8K citations
Life Sciences, Genetics, Oncology +17
J. Yun Tso, Xiao-Hong Sun, Teh‐hui Kao et al. · Nucleic Acids Research · 1985 · 1.8K citations · Full text
Deborah J. Good, Peter J. Polverini, Farzan Rastinejad et al. · Proceedings of the National Academy of Sciences · 1990 · 1.1K citations · Full text